Skip to main content
OpenTrials

Clinical trial condition

Uterine Cervical Neoplasms

Explore clinical trials studying Uterine Cervical Neoplasms. Study availability and eligibility vary by location and protocol.

1,609 public trials 365 recruiting studies
Refine in advanced search Browse all conditions

Uterine Cervical Neoplasms trial results

Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT06172478

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +70 more
Locations
  • City of Hope Duarte, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • AdventHealth Medical Group Oncology Research at Celebration Kissimmee, Florida, United States
  • University of Illinois Cancer Center Chicago, Illinois, United States
View all 90 locations
View Trial Details
Recruiting

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

NCT06400472

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +42 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • NYU Langone Health - Long Island Mineola, New York, United States
View all 24 locations
View Trial Details
Recruiting

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

NCT06952660

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • HonorHealth Cancer Care - Biltmore - AZCCC Imaging Phoenix, Arizona, United States
  • HonorHealth Cancer Care - Biltmore - HonorHealth Research Pharmacy Phoenix, Arizona, United States
  • HonorHealth Research Institute (Arizona Center for Cancer Care) - HonorHealth Cancer Care -Biltmore Phoenix, Arizona, United States
  • Sonora Quest Laboratories, LLC Phoenix, Arizona, United States
View all 130 locations
View Trial Details
Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

NCT06760819

Conditions
Adnexal Diseases, Advanced Solid Tumors, Biliary Tract Diseases, +53 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus Fort Myers, Florida, United States
  • Dana-Farber Cancer Institute - Oncology Department Boston, Massachusetts, United States
View all 54 locations
View Trial Details
Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

NCT07216703

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • Florida Cancer Specialists - South ( Site 7001) Fort Myers, Florida, United States
  • Mount Sinai Comprehensive Cancer Center ( Site 6000) Miami Beach, Florida, United States
  • Florida Cancer Specialists - East ( Site 7000) West Palm Beach, Florida, United States
  • Winship Cancer Institute of Emory University ( Site 5005) Atlanta, Georgia, United States
View all 172 locations
View Trial Details

Related conditions